BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 10401913)

  • 21. Augmentation of clozapine with valproic Acid for clozapine-induced obsessive-compulsive symptoms.
    Zink M; Englisch S; Knopf U; Kuwilsky A; Dressing H
    Pharmacopsychiatry; 2007 Sep; 40(5):202-3. PubMed ID: 17874353
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of typical antipsychotic medications and clozapine on smooth pursuit performance in patients with schizophrenia.
    Friedman L; Jesberger JA; Meltzer HY
    Psychiatry Res; 1992 Jan; 41(1):25-36. PubMed ID: 1348583
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clozapine for treatment-refractory schizophrenia, schizoaffective disorder, and psychotic bipolar disorder: a 24-month naturalistic study.
    Ciapparelli A; Dell'Osso L; Pini S; Chiavacci MC; Fenzi M; Cassano GB
    J Clin Psychiatry; 2000 May; 61(5):329-34. PubMed ID: 10847306
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Integration of Clozapine-associated Harm Obsessions into Cognitive Behavioral Conceptualization and Treatment Planning for Thought Broadcasting: A Case Study.
    Kopelovich SL; Wood K; Cotes RO; Goldsmith DR
    J Psychiatr Pract; 2020 Jul; 26(4):329-336. PubMed ID: 32692132
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Switching clozapine responders to olanzapine.
    Littrell KH; Johnson CG; Hilligoss NM; Peabody CD; Littrell SH
    J Clin Psychiatry; 2000 Dec; 61(12):912-5. PubMed ID: 11206595
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Obsessive-compulsive symptoms in clozapine-treated schizophrenic patients.
    Ertugrul A; Anil Yagcioglu AE; Eni N; Yazici KM
    Psychiatry Clin Neurosci; 2005 Apr; 59(2):219-22. PubMed ID: 15823172
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Marked liver enzyme elevations with clozapine.
    Markowitz JS; Grinberg R; Jackson C
    J Clin Psychopharmacol; 1997 Feb; 17(1):70-1. PubMed ID: 9004073
    [No Abstract]   [Full Text] [Related]  

  • 28. Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder.
    Volavka J; Czobor P; Sheitman B; Lindenmayer JP; Citrome L; McEvoy JP; Cooper TB; Chakos M; Lieberman JA
    Am J Psychiatry; 2002 Feb; 159(2):255-62. PubMed ID: 11823268
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of psychosis and clozapine load in excessive checking in treatment-resistant schizophrenia: longitudinal observational study.
    Fernandez-Egea E; Chen S; Sangüesa E; Gassó P; Biria M; Plaistow J; Jarratt-Barnham I; Segarra N; Mas S; Ribate MP; García CB; Fineberg NA; Worbe Y; Cardinal RN; Robbins TW
    Br J Psychiatry; 2024 May; 224(5):164-169. PubMed ID: 38652060
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Obsessive-compulsive disorder in UK clozapine-treated schizophrenia and schizoaffective disorder: a cause for clinical concern.
    Mukhopadhaya K; Krishnaiah R; Taye T; Nigam A; Bailey AJ; Sivakumaran T; Fineberg NA
    J Psychopharmacol; 2009 Jan; 23(1):6-13. PubMed ID: 18515449
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clozapine-induced obsessive-compulsive syndromes improve in combination with aripiprazole.
    Englisch S; Esslinger C; Inta D; Weinbrenner A; Peus V; Gutschalk A; Schirmbeck F; Zink M
    Clin Neuropharmacol; 2009; 32(4):227-9. PubMed ID: 19644230
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clozapine and recidivism.
    Gordon BJ; Milke DJ
    Psychiatr Serv; 1995 Oct; 46(10):1079. PubMed ID: 8829795
    [No Abstract]   [Full Text] [Related]  

  • 33. Clozapine and haloperidol in moderately refractory schizophrenia: a 6-month randomized and double-blind comparison.
    Kane JM; Marder SR; Schooler NR; Wirshing WC; Umbricht D; Baker RW; Wirshing DA; Safferman A; Ganguli R; McMeniman M; Borenstein M
    Arch Gen Psychiatry; 2001 Oct; 58(10):965-72. PubMed ID: 11576036
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Obsessive-compulsive symptoms associated with clozapine and risperidone treatment: three case reports and review of the literature.
    Ke CL; Yen CF; Chen CC; Yang SJ; Chung W; Yang MJ
    Kaohsiung J Med Sci; 2004 Jun; 20(6):295-301. PubMed ID: 15253471
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clozapine-induced obsessive-compulsive disorder: a case report].
    Sánchez Bonome L; Barjau Romero JM; Lara Muñoz Rd; Márquez Tejero MC
    Actas Esp Psiquiatr; 2002; 30(5):330-4. PubMed ID: 12372230
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emergence of obsessive compulsive symptoms during treatment with clozapine.
    Baker RW; Chengappa KN; Baird JW; Steingard S; Christ MA; Schooler NR
    J Clin Psychiatry; 1992 Dec; 53(12):439-42. PubMed ID: 1487472
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of clozapine on tardive dyskinesia.
    Lieberman JA; Saltz BL; Johns CA; Pollack S; Borenstein M; Kane J
    Br J Psychiatry; 1991 Apr; 158():503-10. PubMed ID: 1675900
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Obsessive-compulsive symptoms and clozapine.
    Dursun SM; Reveley MA
    Br J Psychiatry; 1994 Aug; 165(2):267-8. PubMed ID: 7953043
    [No Abstract]   [Full Text] [Related]  

  • 39. Higher plasma drug concentration in clozapine-treated schizophrenic patients with side effects of obsessive/compulsive symptoms.
    Lin SK; Su SF; Pan CH
    Ther Drug Monit; 2006 Jun; 28(3):303-7. PubMed ID: 16778711
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of clozapine, olanzapine, risperidone, and haloperidol in schizophrenia and schizoaffective disorder assessed with nurses observation scale for inpatient evaluation.
    Volavka J; Nolan KA; Kline L; Czobor P; Citrome L; Sheitman B; Lindenmayer JP; McEvoy J; Lieberman JA
    Schizophr Res; 2005 Jul; 76(1):127-9. PubMed ID: 15927808
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.